PT Itama Ranoraya Tbk (IDX:IRRA)
Indonesia · Delayed Price · Currency is IDR
396.00
-6.00 (-1.49%)
Mar 3, 2026, 2:58 PM WIB
Revenue by Segment
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 48.89B | 3.53B | 64.14B | 12.45B | 5.31B | | | | |
| 1284.95% | -94.50% | 415.40% | 134.30% | -71.10% | | | | |
Sterile Non-Electromedical Medical Equipment | 41.78B | 64.36B | 139.93B | 141.23B | 147.77B | | | | |
Sterile Non-Electromedical Medical Equipment Growth | -35.08% | -54.01% | -0.92% | -4.43% | 24.81% | | | | |
In Vitro Diagnostic Products | 351.94B | 215.80B | 505.62B | 1.17T | 410.80B | | | | |
In Vitro Diagnostic Products Growth | 63.09% | -57.32% | -56.64% | 183.85% | 183.37% | | | | |
Electromedical Medical Equipment | 534.88B | 412.61B | 43.88B | - | - | | | | |
Electromedical Medical Equipment Growth | 29.63% | 840.42% | - | - | - | | | | |
| 977.49B | 696.30B | 753.57B | 1.32T | 563.89B | | | | |
| 40.38% | -7.60% | -42.90% | 134.04% | 100.14% | | | | |
Revenue by Geography
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 977.49B | 696.30B | 753.57B | 1.32T | 563.89B | | | | |
| 40.38% | -7.60% | -42.90% | 134.04% | 100.14% | | | | |
| 977.49B | 696.30B | 753.57B | 1.32T | 563.89B | | | | |
| 40.38% | -7.60% | -42.90% | 134.04% | 100.14% | | | | |
Source: S&P Global Market Intelligence.